Similar results were obtained exploiting Haspin chemical inhibitor 5-ITu in differentiated neuroblastoma SH-SY5Y cells (Figure 2d and Figure S1h as expression levels of MAP2 and RARb gene as a differentiation control, primers used are listed in Table 1). The gene discussed is HASPIN; the disease is neuroblastoma.